ViroGates Past Earnings Performance

Past criteria checks 0/6

ViroGates has been growing earnings at an average annual rate of 11.6%, while the Medical Equipment industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 23.9% per year.

Key information

11.6%

Earnings growth rate

14.5%

EPS growth rate

Medical Equipment Industry Growth-1.7%
Revenue growth rate23.9%
Return on equity-95.1%
Net Margin-171.6%
Next Earnings Update15 Aug 2024

Recent past performance updates

Recent updates

ViroGates (CPH:VIRO) Is In A Good Position To Deliver On Growth Plans

Mar 06
ViroGates (CPH:VIRO) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That ViroGates (CPH:VIRO) Will Use Its Cash Wisely

Nov 21
We're Hopeful That ViroGates (CPH:VIRO) Will Use Its Cash Wisely

Will ViroGates (CPH:VIRO) Spend Its Cash Wisely?

Jun 14
Will ViroGates (CPH:VIRO) Spend Its Cash Wisely?

We're Not Very Worried About ViroGates' (CPH:VIRO) Cash Burn Rate

Sep 19
We're Not Very Worried About ViroGates' (CPH:VIRO) Cash Burn Rate

We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

Apr 14
We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

Dec 30
We Think ViroGates (CPH:VIRO) Can Afford To Drive Business Growth

Revenue & Expenses Breakdown
Beta

How ViroGates makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CPSE:VIRO Revenue, expenses and earnings (DKK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 247-13127
31 Dec 237-12126
30 Sep 239-11127
30 Jun 2311-11129
31 Mar 2313-101210
31 Dec 2215-101311
30 Sep 2214-121410
30 Jun 2212-13168
31 Mar 229-16187
31 Dec 218-18197
30 Sep 217-18196
30 Jun 218-18196
31 Mar 217-17176
31 Dec 205-19186
30 Sep 204-21195
30 Jun 202-21195
31 Mar 203-21196
31 Dec 194-19176
30 Sep 194-16249
30 Jun 194-14227
31 Mar 194-1870
31 Dec 183-17174
30 Sep 183-1550
30 Jun 183-1450
31 Mar 182-740
31 Dec 172-630
31 Dec 164-530
31 Dec 154-440

Quality Earnings: VIRO is currently unprofitable.

Growing Profit Margin: VIRO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: VIRO is unprofitable, but has reduced losses over the past 5 years at a rate of 11.6% per year.

Accelerating Growth: Unable to compare VIRO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VIRO is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.8%).


Return on Equity

High ROE: VIRO has a negative Return on Equity (-95.07%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.